Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003-2018).
HIV
pharmacotherapy
smoking
smoking cessation medications
veterans
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
28
10
2022
accepted:
16
02
2023
entrez:
27
3
2023
pubmed:
28
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown. We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003-2018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0-365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH. The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994-1.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040-1.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036-1.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004-1.009]). In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking.
Sections du résumé
Background
UNASSIGNED
Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown.
Methods
UNASSIGNED
We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003-2018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0-365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH.
Results
UNASSIGNED
The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994-1.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040-1.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036-1.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004-1.009]).
Conclusions
UNASSIGNED
In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking.
Identifiants
pubmed: 36968969
doi: 10.1093/ofid/ofad089
pii: ofad089
pmc: PMC10034589
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofad089Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. All authors: No reported conflicts of interest.
Références
Am J Public Health. 2010 Oct;100(10):1896-903
pubmed: 20724677
AIDS Patient Care STDS. 2012 Jan;26(1):12-9
pubmed: 22007690
Nurs Adm Q. 2015 Oct-Dec;39(4):311-8
pubmed: 26340242
JAMA. 2016 Jan 26;315(4):371-9
pubmed: 26813210
Med Care. 2006 Aug;44(8 Suppl 2):S25-30
pubmed: 16849965
Ann Intern Med. 2015 Mar 3;162(5):335-44
pubmed: 25732274
J Health Soc Behav. 2010;51 Suppl:S28-40
pubmed: 20943581
MMWR Morb Mortal Wkly Rep. 2011 Aug 12;60(31):1045-9
pubmed: 21832975
AIDS Behav. 2017 Jul;21(7):1950-1955
pubmed: 28194586
J Manag Care Spec Pharm. 2016 Sep;22(9):1058-63
pubmed: 27579828
Prev Med. 2018 Jun;111:231-234
pubmed: 29550303
Enferm Infecc Microbiol Clin. 2006 Oct;24(8):509-11
pubmed: 16987469
Clin Infect Dis. 2007 Jul 1;45(1):103-10
pubmed: 17554710
Ann Intern Med. 2000 Mar 7;132(5):369-72
pubmed: 10691587
AIDS. 2012 May 15;26(8):1017-25
pubmed: 22382152
Nicotine Tob Res. 2013 Aug;15(8):1436-45
pubmed: 23430708
Nicotine Tob Res. 2011 Dec;13(12):1233-9
pubmed: 21911825
Med Care. 1985 Dec;23(12):1358-71
pubmed: 3910973
Chest. 2006 Nov;130(5):1326-33
pubmed: 17099007
Am Heart J. 2006 Jun;151(6):1147-55
pubmed: 16781213
Issues Ment Health Nurs. 2012 Oct;33(10):665-9
pubmed: 23017042
Med Care. 2006 Aug;44(8 Suppl 2):S13-24
pubmed: 16849964
J Gen Intern Med. 1999 May;14(5):274-80
pubmed: 10337036
JAMA. 2000 Jun 28;283(24):3244-54
pubmed: 10866874
Mil Med. 2009 Jan;174(1):29-34
pubmed: 19216295
Lancet. 2016 Jun 18;387(10037):2507-20
pubmed: 27116918
Clin Pharmacol Ther. 2007 Jan;81(1):69-75
pubmed: 17186001
Am J Public Health. 2008 Feb;98(2):216-21
pubmed: 18172133
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
JAMA Psychiatry. 2013 May;70(5):522-33
pubmed: 23536105
Drug Alcohol Depend. 2020 Aug 1;213:108128
pubmed: 32603975
Med Care. 1998 Jul;36(7):1085-97
pubmed: 9674625
Addict Res Theory. 2015 Feb;23(1):10-23
pubmed: 28529471
Nicotine Tob Res. 2021 Aug 4;23(8):1308-1317
pubmed: 33856483
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742
pubmed: 33211681
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085
Prog Cardiovasc Dis. 2020 Mar - Apr;63(2):118-124
pubmed: 31987807
AIDS. 2015 Jan 14;29(2):221-9
pubmed: 25426809
Int J Chron Obstruct Pulmon Dis. 2008;3(1):45-53
pubmed: 18488428